Organ-Specific Roles of CYP1A1 during Detoxication of Dietary Benzo[a]pyrene

Polycyclic aromatic hydrocarbons (PAHs) are widely distributed environmental toxicants derived from sources that include cigarette smoke, petroleum distillation, gas- and diesel-engine exhaust, and charcoal-grilled food. The gastrointestinal tract is the principal route of PAH exposures, even when inhaled. The most thoroughly studied prototype of PAHs is benzo[a]pyrene (BaP), well known to be toxic, mutagenic, and carcinogenic in various tissues and cell types. This lab has previously shown that Cyp1a1(−/−) global knockout mice treated by oral administration of BaP die at 28 to 32 days with immunosuppression, whereas wild-type mice remain healthy for 1 year on high BaP doses (125 mg/kg/day). Thus, for oral BaP, CYP1A1 is more important in detoxication than in metabolic activation. After several days of oral BaP, we found surprisingly low CYP1A1 levels in liver, compared with that in small intestine; we postulated that this finding might reflect efficient detoxication of oral BaP in proximal small intestine such that significant amounts of the inducer BaP no longer reach the liver. In the present study, many parameters were therefore compared in wild-type, Cyp1a1(−/−) global knockout, intestinal epithelial cell-specific Cyp1a1 knockout, and hepatocyte-specific Cyp1a1 knockout mice as a function of long-term oral exposure to BaP. The peak of CYP1A1 (mRNA, protein) expression in liver occurred at 12 h, whereas highly induced CYP1A1 in small intestine persisted throughout the 30-day experiment. Hepatocyte-specific Cyp1a1 knockout mice remained as healthy as wild-type mice; intestinal epithelial cell-specific Cyp1a1 knockout mice behaved like Cyp1a1(−/−) mice, dying with immunosuppression ∼30 days on oral BaP. We conclude that small intestine CYP1A1, and not liver CYP1A1, is critically important in oral BaP detoxication.

[1]  C. Rubio,et al.  Oral benzo[a]pyrene‐induced cancer: Two distinct types in different target organs depend on the mouse Cyp1 genotype , 2010, International journal of cancer.

[2]  J. Tayek,et al.  Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[3]  D. Nebert,et al.  Knock-In Mouse Lines Expressing either Mitochondrial or Microsomal CYP1A1: Differing Responses to Dietary Benzo[a]pyrene as Proof of Principle , 2009, Molecular Pharmacology.

[4]  D. Nebert,et al.  Endogenous Functions of the Aryl Hydrocarbon Receptor (AHR): Intersection of Cytochrome P450 1 (CYP1)-metabolized Eicosanoids and AHR Biology* , 2008, Journal of Biological Chemistry.

[5]  J. Perrone,et al.  Acetaminophen-induced nephrotoxicity: Pathophysiology, clinical manifestations, and management , 2008, Journal of Medical Toxicology.

[6]  J. Ozer,et al.  The current state of serum biomarkers of hepatotoxicity. , 2008, Toxicology.

[7]  D. Nebert,et al.  Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. , 2008, Free radical biology & medicine.

[8]  Y. Maehara,et al.  Impact of Smoking Status on the Biological Behavior of Lung Cancer , 2007, Surgery Today.

[9]  F. Gonzalez,et al.  Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. , 2007, The Journal of clinical investigation.

[10]  D. Nebert,et al.  Hepatocyte‐specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure , 2007, Hepatology.

[11]  D. Nebert,et al.  The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis , 2006, Nature Reviews Cancer.

[12]  S. Duncan,et al.  Generation of mice harbouring a conditional loss-of-function allele of Gata6 , 2006, BMC Developmental Biology.

[13]  D. Nebert,et al.  Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate , 2006, Molecular Pharmacology.

[14]  E. Roberts,et al.  Non-alcoholic fatty liver disease (NAFLD) in children. , 2005, Frontiers in bioscience : a journal and virtual library.

[15]  Allan B. Okey,et al.  Role of Aryl Hydrocarbon Receptor-mediated Induction of the CYP1 Enzymes in Environmental Toxicity and Cancer* , 2004, Journal of Biological Chemistry.

[16]  D. Nebert,et al.  Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. , 2004, Molecular pharmacology.

[17]  D. Nebert,et al.  Balancer-Cre transgenic mouse germ cells direct the incomplete resolution of a tri-loxP-targeted Cyp1a1 allele, producing a conditional knockout allele. , 2003, Biochemical and biophysical research communications.

[18]  Shih-Shun Chen,et al.  Liver-Specific Reactivation of the Inactivated Hnf-1α Gene: Elimination of Liver Dysfunction To Establish a Mouse MODY3 Model , 2003, Molecular and Cellular Biology.

[19]  H. Rubin Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. , 2001, Carcinogenesis.

[20]  Z. Kmieć,et al.  Cooperation of Liver Cells in Health and Disease , 2001, Advances in Anatomy Embryology and Cell Biology.

[21]  K. Miller,et al.  IMPACT OF CELLULAR METABOLISM ON THE BIOLOGICAL EFFECTS OF BENZO[A]PYRENE AND RELATED HYDROCARBONS† , 2001, Drug metabolism reviews.

[22]  M. Medvedovic,et al.  The transcriptional signature of dioxin in human hepatoma HepG2 cells. , 2000, Biochemical pharmacology.

[23]  D. Nebert,et al.  “Gene‐Swap Knock‐in” Cassette in Mice to Study Allelic Differences in Human Genes , 2000, Annals of the New York Academy of Sciences.

[24]  B. Lee,et al.  Lipid peroxidation, antioxidant enzymes, and benzo[a]pyrene-quinones in the blood of rats treated with benzo[a]pyrene. , 2000, Chemico-biological interactions.

[25]  D. Nebert,et al.  Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery. , 2000, Biochemical and biophysical research communications.

[26]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[27]  C. McClain,et al.  Acetaminophen hepatotoxicity: An update , 1999, Current gastroenterology reports.

[28]  A. J. Smith,et al.  Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guineapig, ferret and mink , 1998, Laboratory animals.

[29]  Kathleen I. Pinson,et al.  Targeted disruption of the mouse villin gene does not impair the morphogenesis of microvilli , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[30]  M. Verma,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes. , 1996, The Journal of pharmacology and experimental therapeutics.

[31]  M. A. Yusty,et al.  Determination of benzo[a]pyrene in lipid-soluble liquid smoke (LSLS) by HPLC-FL. , 1996 .

[32]  A. M. Pupin,et al.  Benzo(a)pyrene in Brazilian vegetable oils. , 1996, Food additives and contaminants.

[33]  H. Herlong Approach to the patient with abnormal liver enzymes. , 1994, Hospital practice.

[34]  E. Brown Mixed anionic detergent/aliphatic alcohol-polyacrylamide gel electrophoresis alters the separation of proteins relative to conventional sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1988, Analytical biochemistry.

[35]  D. Nebert,et al.  Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes. , 1985, The Journal of biological chemistry.

[36]  D. Nebert,et al.  Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. , 1982, Pharmacological reviews.

[37]  J. Santodonato,et al.  Health and ecological assessment of polynuclear aromatic hydrocarbons. , 1981, Journal of environmental pathology and toxicology.

[38]  S. Thorgeirsson,et al.  Relationship between "aromatic hydrocarbon responsiveness" and the survival times in mice treated with various drugs and environmental compounds. , 1975, Molecular pharmacology.

[39]  Margarete M. Kunde,et al.  STUDIES ON METABOLISM , 1927 .

[40]  Lars Järup,et al.  Hazards of heavy metal contamination. , 2003, British medical bulletin.

[41]  D. Nebert,et al.  Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. , 2000, Biochemical pharmacology.

[42]  J. Simal Lozano,et al.  Determination of benzo[a]pyrene in lipid-soluble liquid smoke (LSLS) by HPLC-FL. , 1996, Food additives and contaminants.

[43]  P. Lioy,et al.  An assessment of a urinary biomarker for total human environmental exposure to benzo[a]pyrene , 1995, International archives of occupational and environmental health.

[44]  D. Jerina,et al.  Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. , 1994, Drug metabolism reviews.

[45]  G. Kroemer,et al.  Compartmentalization of the peripheral immune system. , 1993, Advances in immunology.

[46]  D W Nebert,et al.  The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. , 1989, Critical reviews in toxicology.

[47]  L. Marnett,et al.  Metabolic activation of 7,8-dihydroxy-7,8-dihydrobenzo[a]-pyrene during prostaglandin biosynthesis. , 1982, Drug metabolism reviews.

[48]  C. D. Klaasen Casarett & Doull's Toxicology: The Basic Science of Poisons , 1980 .